Challenger Ltd Posts 3% FY26 Profit Lift and Upsizes Buyback to $450M

Challenger Limited (ASX: CGF) posted a 3% rise in normalised NPAT to $468 million in its Challenger Ltd FY26 Results, declaring a 7% dividend increase and upsizing its share buy-back to $450 million on the back of record annuity sales and a favourable APRA capital overhaul.
By Josua Ferreira -
  • Challenger reported normalised NPAT of $468 million for FY26, up 3% and in line with guidance, with statutory NPAT jumping to $506 million from $192 million the prior year on positive asset and liability experience.
  • Annuity sales reached a record $6.2 billion, up 19%, driving annuity book growth of 10.7% and underpinning the Life segment's normalised NPAT of $471 million.
  • The board declared a fully franked ordinary dividend of 31.5 cents per share (up 7%) plus a 1.5 cent special dividend, and upsized the total on-market share buy-back program to $450 million — including a new $300 million tranche announced 18 August 2026.
  • The APRA capital framework overhaul, effective 1 July 2026, lowered required capital levels and directly enabled the scale of shareholder returns, with Challenger holding $1.1 billion in excess capital above the regulatory minimum.
  • FY27 Core Basic EPS guidance of 45–49 cents per share implies 6% growth at the midpoint, supported by the new $6 billion Challenger Annuity-Backed Notes program launched in July 2026 as a fresh institutional funding channel.
Summarise with AI:

Challenger delivers 3% profit lift, upsizes buy-back to $450 million in FY26 results

In its FY26 full-year results for the period ending 30 June 2026, Challenger Limited (ASX: CGF) reported normalised net profit after tax (NPAT) of $468 million, up 3% and in-line with earnings guidance.

Managing Director and Chief Executive Officer Nick Hamilton framed the year as one of successful strategy execution, with growing momentum across the business. Australia’s leading retirement income business also lifted returns to shareholders, declaring a fully franked full-year ordinary dividend of 31.5 cents per share (up 7%) plus a 1.5 cents per share special dividend, and upsizing its on-market share buy-back to a total of $450 million.

FY26 financial results at a glance

Challenger delivered growth across its headline measures during the reporting period. Normalised NPAT rose 3% to $468 million, while statutory NPAT increased to $506 million from $192 million in FY25, supported by higher normalised earnings and positive asset and liability experience.

Challenger FY26 Key Financial Highlights

Normalised earnings per share (EPS) grew 3% to 68.1 cents, and normalised return on equity (ROE) of 11.6% remained above the 10.9% target, though this represented a decrease of 20 basis points from FY25’s 11.8%. Annuity sales climbed 19% to $6.2 billion, driving annuity book growth of 10.7%.

Metric FY26 FY25 Change
Normalised NPAT ($m) 468 456 3%
Statutory NPAT ($m) 506 192 163%
Normalised EPS (cps) 68.1 66.3 3%
Normalised ROE (%) 11.6 11.8 (20 bps)
Total Life sales ($bn) 9.6 8.6 12%
Annuity sales ($bn) 6.2 5.2 19%
Full-year ordinary dividend (cps) 31.5 29.5 7%
CLC PCA ratio (times) 1.38 1.60 (0.22)

Nick Hamilton, Managing Director & CEO

“Our FY26 result reflects the successful execution of our strategy and the growing momentum across our business. We delivered strong earnings, increased annuity sales and continued to invest in the strategic priorities that will support Challenger’s future growth.”

Life and Funds Management drive the result

Record annuity sales power the Life business

The Life segment recorded normalised NPAT growth of 2% to $471 million, reflecting higher normalised cash operating earnings from growth in average investment assets, which rose 6% to $26.2 billion. Total Life sales increased 12% to $9.6 billion, supporting Life book growth of 9.2%.

Domestic annuity sales grew 17% to $4.9 billion, driven by a 19% increase in fixed term annuity sales and a 13% increase in lifetime annuities. CarePlus, a lifetime annuity designed for aged care, achieved its highest yearly sales since launching in 2015.

Offshore reinsurance annuity sales reached a record $1.2 billion, up 25%, reflecting the continued growth of the partnership with Mitsui Sumitomo Primary Life Insurance Company in Japan. The normalised COE margin decreased 13 basis points to 3.06%, primarily reflecting lower yields on fixed income securities in the tight credit spread environment.

Funds Management builds origination partnerships

Funds Management normalised NPAT increased 1% to $53 million, supported by higher net fee income and reduced expenses. The company expanded its asset origination capabilities through new partnerships with Bank of Queensland, Finbase and Spark NZ across Australia and New Zealand.

The BOQ equipment finance partnership, secured earlier in 2026 through a $3.7 billion whole-of-loan sale and a 12-month forward flow arrangement, is one concrete expression of that asset origination push, adding a diversified pool of SME credit assets to support annuity book funding.

Challenger also announced the proposed merger of its multi-affiliate funds management business Fidante with Channel Capital. Subject to regulatory approval, the merger is expected to complete in 1H27, with Challenger owning 45% of the merged entity at completion. Funds Management net flows improved to -$4.1 billion, narrowing from -$11.6 billion in the prior year.

What annuities mean for investors

An annuity is a financial product that converts a person’s accumulated retirement savings into a stream of guaranteed, reliable income, either for a fixed term or for life. Challenger’s “annuity book” represents the total pool of these income commitments on its balance sheet.

The 10.7% annuity book growth recorded in FY26 was supported by record annuity sales across the domestic and offshore segments.

This growth is supported by a structural tailwind, as more Australians move into retirement and seek dependable income solutions. Several factors reinforce demand for the company’s offering:

  • A demographic shift, with an ageing population and rising numbers entering retirement.

  • Partnerships with superannuation funds seeking retirement income solutions for members.

Capital strength funds bigger shareholder returns

Challenger remained strongly capitalised ahead of APRA’s new capital standard framework for longevity products, which came into effect on 1 July 2026. The company reported a PCA ratio of 1.38 times the minimum regulatory requirement (1.50 times pro forma under the new capital standards), with $1.1 billion of capital in excess of APRA’s minimum requirement.

The APRA capital framework overhaul, finalised earlier in 2026 and effective from 1 July, lowered required capital levels and reduced cyclical risk to Challenger’s position during periods of market stress, providing the regulatory tailwind that underpins the board’s confidence in returning capital at this scale.

Reflecting this position, the Board determined a fully franked full-year ordinary dividend of 31.5 cents per share (up 7%) plus a fully franked special dividend of 1.5 cents per share. The share buy-back was upsized to a total of $450 million, comprising two components:

  1. The $150 million on-market share buy-back announced in February 2026, of which approximately $90 million has been completed to date.

  2. A further $300 million on-market buy-back announced today (18 August 2026), subject to market conditions and regulatory approval.

New reporting framework and FY27 outlook

From FY27, Challenger will move to a new Group reporting framework intended to better represent how the business operates and creates value. Under the framework, Core Earnings will comprise Spread Income and Fee-related income net of Operating Expenses, removing all assumption-based normalised accruals for income and capital growth.

For FY27, the company provided Core Basic EPS guidance in a range of 45 to 49 cents per share. The mid-point of 47 cents per share is 6% higher than the FY26 Core EPS of 44.2 cents per share.

The outlook also referenced the $6 billion Challenger Annuity-Backed Notes (CABN) program launched in July 2026, which provides a new institutional funding channel to support annuity book growth and diversification.

Nick Hamilton, Managing Director & CEO

“We enter FY27 with strong momentum and focus on our growth trajectory, reinforcing Challenger’s leadership position in retirement income and creating long-term value for shareholders.”

Stay Ahead on ASX Finance News

Big News Blast delivers FREE breaking ASX announcements straight to your inbox within minutes of release, complete with in-depth analysis already done. Join 20,000+ subscribers who never miss a market-moving update. Click the “Free Alerts” button at Big News Blast to get the next major financial sector announcement before the market moves.


Frequently Asked Questions

What were Challenger's FY26 full-year results?

Challenger Limited reported normalised NPAT of $468 million for FY26, up 3% on the prior year and in line with guidance, with statutory NPAT surging to $506 million from $192 million in FY25. Annuity sales hit a record $6.2 billion, up 19%, and the company declared a fully franked ordinary dividend of 31.5 cents per share plus a 1.5 cent special dividend.

Why did Challenger upsize its share buy-back to $450 million?

The buy-back expansion was underpinned by Challenger's strong capital position, with $1.1 billion in excess capital above APRA's minimum requirement. The new APRA capital framework, effective 1 July 2026, lowered required capital levels and reduced cyclical risk, giving the board confidence to add a further $300 million on-market buy-back on top of the $150 million announced in February 2026.

What is a normalised NPAT and why does Challenger use it?

Normalised net profit after tax (NPAT) adjusts reported earnings to remove the impact of market movements and other items that can distort the underlying performance of the business in any given period. Challenger uses it to give investors a clearer view of recurring earnings power, separate from volatile mark-to-market swings — which is why FY26 normalised NPAT of $468 million is the headline figure, even though statutory NPAT came in higher at $506 million.

What is Challenger's FY27 earnings guidance?

Challenger provided Core Basic EPS guidance of 45 to 49 cents per share for FY27, with the midpoint of 47 cents representing 6% growth over the FY26 Core EPS of 44.2 cents. From FY27, the company is also moving to a new Group reporting framework that removes assumption-based normalised accruals to better reflect how the business operates.

What is the Fidante and Channel Capital merger about?

Challenger has proposed merging its multi-affiliate funds management business Fidante with Channel Capital, with Challenger expected to own 45% of the merged entity upon completion. The deal is subject to regulatory approval and is expected to close in the first half of FY27, as part of Challenger's broader strategy to build out its asset origination and funds management capabilities.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More
Companies Mentioned in Article

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher